To the contrary, IDH2 mutation predominantly hotspot R140 correlates with a more positive clinical prognosis than other mutation sites, although their precise role in AML remains somewhat controversial [19, 20]. The gene discussed is IDH2; the disease is acute myeloid leukemia.